Elsevier Inc.

SHERPA: Unknown

People

  1. Riely
    Riely
  2. Kris
    Kris
  3. Yu
    Yu
  4. Ladanyi
    Ladanyi
  5. Drilon
    Drilon
  6. Rekhtman
    Rekhtman
  7. Miller
    Miller
  8. Huang
    Huang
  9. Rusch
    Rusch
  10. Arcila
    Arcila

Groups

  1. Department of Medicine (133)
  2. Solid Tumor Oncology Division (133)
  3. Thoracic Oncology (133)
  4. GSK Faculty (45)
  5. Human Oncology and Pathogenesis Program (36)
  6. Surgery (32)
  7. Tow Center for Developmental Oncology (TCDO) (32)
  8. Epidemiology and Biostatistics (25)
  9. Biostatistics Service (24)
  10. Survivorship Research (24)
Search Within
  1. "Gregory Riely"
Formats
  1. Meeting Abstract (81)
  2. Journal Article (52)
Groups
  1. Department of Medicine (133)
  2. Solid Tumor Oncology Division (133)
  3. Thoracic Oncology (133)
  4. GSK Faculty (45)
  5. Human Oncology and Pathogenesis Program (36)
  6. Surgery (32)

More Groups

People
  1. Gregory Riely (133)
  2. Mark Kris (46)
  3. Marc Ladanyi (32)
  4. Helena Yu (25)
  5. Natasha Rekhtman (20)
  6. Alexander Drilon (17)

More People

Years
  1. 2023 (9)
  2. 2022 (4)
  3. 2021 (9)
  4. 2020 (6)
  5. 2019 (8)
  6. 2018 (9)

More Years

Publications
  1. Journal of Thoracic Oncology (110)
  2. International Journal of Radiation Oncology, Biology, Physics (11)
  3. European Journal of Cancer (4)
  4. Clinical Lung Cancer (3)
  5. Clinical Imaging (1)
  6. Contemporary Clinical Trials (1)

More Publications

Results (133)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Using patient-level data from electronic health records to replicate PFS outcomes for four 1L NSCLC trials
    Meeting Abstract

    Bretscher, M.; Machado, R.; Ton, T.; Pal, N.; Trinh, H.; Mahrus, S.; Riely, G.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Mobocertinib in NSCLC with EGFR exon 20 insertions: Results from EXCLAIM and pooled platinum-pretreated patient populations
    Meeting Abstract

    Zhou, C.; Ramalingam, S.; Li, B.; Fang, J.; Kim, T. M.; Kim, S.; Yang, J. C.; Riely, G.; Mekhail, T.; Nguyen, D.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Circulating tumor DNA as a biomarker in oligometastatic non-small cell lung cancer
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y.; Razavi, P.; Reis, J. S.; Flynn, J.; Zhang, Z.; Tu, H. Y.; Bertucci, C.; Lim, L. P.; Li, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in advanced/ metastatic non-small-cell lung cancer (NSCLC) harboring KRAS G12C mutation
    Meeting Abstract

    Jänne, P. A.; Rybkin, I. I.; Spira, A. I.; Riely, G. J.; Papadopoulos, K. P.; Sabari, J. K.; Johnson, M. L.; Heist, R. S.; Bazhenova, L.; Barve, M.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: A multicentre, open-label, phase 1 study
    Journal Article

    Tan, D. S. W.; Leighl, N. B.; Riely, G. J.; Yang, J. C. H.; Sequist, L. V.; Wolf, J.; Seto, T.; Felip, E.; Aix, S. P.; Jonnaert, M.; more...
    The Lancet Respiratory Medicine (2020)

    Fulltext@MSK | Save
  • The genomic landscape of SMARCA4 alterations and association with patient outcomes in lung cancer
    Meeting Abstract

    Schoenfeld, A. J.; Montecalvo, J.; Namakydoust, A.; Lavery, J.; Bandlamudi, C.; Rizvi, H.; Paul, S.; Arcila, M.; Chang, J.; Sauter, J.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas
    Journal Article

    Rekhtman, N.; Montecalvo, J.; Chang, J. C.; Alex, D.; Ptashkin, R. N.; Ai, N.; Sauter, J. L.; Kezlarian, B.; Jungbluth, A.; Desmeules, P.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy of platinum/pemetrexed combination chemotherapy in ALK-positive NSCLC refractory to second-generation ALK inhibitors
    Journal Article

    Lin, J. J.; Schoenfeld, A. J.; Zhu, V. W.; Yeap, B. Y.; Chin, E.; Rooney, M.; Plodkowski, A. J.; Digumarthy, S. R.; Dagogo-Jack, I.; Gainor, J. F.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • A novel activating MAP2K1 in-frame deletion mediates acquired resistance to ROS1 TKIs in a patient with ROS1 fusion-positive NSCLC
    Meeting Abstract

    Sato, H.; Schoenfeld, A.; Siau, E.; Suzawa, K.; Yue, C.; Offin, M.; Drilon, A.; Davare, M.; Riely, G.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Tissue-based molecular and histologic landscape of acquired resistance to osimertinib in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A.; Chan, J.; Rizvi, H.; Somwar, R.; Kubota, D.; Daneshbod, Y.; Chang, J.; Offin, M.; Arcila, M.; Pe'Er, D.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save